Hope and advances in research
Testimonial
These authentic narratives showcase the experiences of individuals who have benefited from the latest medical advancements and innovative treatments. Their testimonials provide an inspiring glimpse into the progress made in the fight against the disease, as well as encouraging perspectives for the future.
Testimonial of Robert and his son, Jean-Marc Evenat
Testimonial of Ovila Blanchard
Testimonial of Roger et Claire Kelly
Additional Information - Testimonials
Advanced prostate cancer treatments strategies
Strategies for treating advanced cancer have significantly evolved, offering new options and hope for patients.
Prostate Cancer Study Results Summaries (2023 ASCO-GU)
Summary of clinical trial results on promising prostate cancer research.
Advanced Prostate Cancer Triple Therapy Study Results (2023 ASCO-GU)
Clinical trial results on triple therapy for advanced hormone-sensitive prostate cancer.
Expert Opinion: Prostate Cancer and Hormone Therapy
What you need to know about hormone therapy and how to manage the side effects of this treatment.
Prostate cancer and nuclear medicine
What about nuclear medicine? Is it suitable for your situation?
Nuclear imaging technologies
Has your doctor suggested prostate imaging tests? Explore options like PSMA PET scans.
Targeted therapy and inherited mutations
If you have a specific genetic mutation, you could benefit from new targeted treatments.
States of prostate cancer following treatment
Do your recent tests show an increase in PSA levels? It could indicate a recurrence.
The role of hormone therapy
Has your doctor recommended hormone therapy? This video is for you!
Advanced prostate cancer treatment strategies
Strategies for treating advanced cancer have significantly evolved, offering new options and hope for patients.
Advanced prostate cancer treatment
Advanced prostate cancer encompasses various conditions, including metastatic, recurrent, and hormone-resistant forms, each raising different questions and concerns.
When prostate cancer comes back
A recurrence is when the cancer returns after treatment. The main question is, “What’s next?”
How to treat advanced prostate cancer
Advanced prostate cancer encompasses various conditions, including metastatic, recurrent, and hormone-resistant forms, each raising different questions and concerns.
All about hormone therapy
Hormone therapy can reduce tumor size, control cancer, and prolong life. Is it the right treatment for your cancer?
Q-A – New therapies for advance prostate cancer
In this interview, we answer patients’ questions about new therapies for advanced prostate cancer.
Am I a good candidate for radioligand therapy?
Find out if you are eligible for radioligand therapy for prostate cancer, how the treatment works, and the precautions to follow.
Radioligand therapy: a promising option
Learn how radioligand therapy helps slow advanced prostate cancer and why access to this treatment varies across Canada.
Biomarkers: guiding treatment decisions
Discover how biomarkers personalize and guide prostate cancer treatment decisions for each patient.
Biomarkers: better understanding prostate cancer
Learn how biomarkers enable more precise monitoring and treatment of prostate cancer.
A recurrence does not mean the end
Discover the available treatments, new targeted therapies, and the next steps in managing a prostate cancer recurrence.
The effects of hormone therapy and PARP inhibitors
Learn how hormone therapy and PARP inhibitors work in your body and what side effects to anticipate.
Bone scan: detecting bone metastases
When prostate cancer progresses to an advanced stage, it can spread to the bones. This is where a bone scan plays a role.
Prostate cancer: better understanding your tests
Understand the purpose of your tests (PSA, MRI, PSMA PET scan, biopsy, bone scan) to better navigate them.
Prostate cancer: better understanding hormone therapy
Which approach is better: continuous or intermittent hormone therapy?
Sources and references
Last medical and editorial review: April 2024. See our web page validation committee and our collaborators by clicking here.